SEC Form 4 · accession 0001225208-15-014567
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald E Morel Jr.
Officer — Chair of the Board & CEO
Period of report
Jun 30, 2015
Accepted (ET)
Jul 1, 2015 · 2:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $58.08 | Jun 30, 2015 | A | 103,184 | A | Jun 30, 2016 | Jun 30, 2025 | Common Stock | 103,184 | 103,184 | D |